Peter Horal
-
High-risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma - A multi-centre study in Sweden, Brazil and
Romania.
Jonas Sundberg, Jenny Öhman, Magdalena Korytowska, Mats Wallström, Göran Kjeller, Maria Andersson, Peter Horal, Magnus Lindh, Daniel Giglio, Anikó Kovács, Lars Sand, Jan-Michaél Hirsch, Lais Magda Araújo Ferracini, Ana Carolina Mamana Fernandes de Souza, Ioanina Parlatescu, Maria Dobre, Mihail-Eugen Hinescu, Paulo Henrique Braz-Silva, Serban Tovaru, Bengt Hasséus
Oral diseases - 2020-01-01 -
Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell
Carcinoma.
Jonas Sundberg, Magdalena Korytowska, Patricia Miranda Burgos, Johan Blomgren, Lena Blomstrand, Shahin DE Lara, Lars Sand, Jan-Micháel Hirsch, Erik Holmberg, Daniel Giglio, Jenny Öhman, Anikó Kovács, Peter Horal, Magnus Lindh, Göran Kjeller, Bengt Hasséus
Anticancer research - 2019-01-01 -
Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical
neoplasia.
Elin Andersson, Cecilia Kärrberg, Thomas Rådberg, Lennart Blomqvist, Britt-Marie Zetterqvist, Walter Ryd, Magnus Lindh, Peter Horal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 2012-01-01 -
Type-specific HPV E6/E7 mRNA detection by real-time PCR improves identification of cervical
neoplasia.
Elin Andersson, Cecilia Kärrberg, Thomas Rådberg, Lennart Blomqvist, Britt-Marie Zetterqvist, Walter Ryd, Magnus Lindh, Peter Horal
Journal of clinical microbiology - 2011-01-01 -
Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and
infectivity
Samir Abdurahman, Akos Vegvari, Masoud Youssefi, Michael Levi, Stefan Hoglund, Elin Andersson, Peter Horal, Bo Svennerholm, Jan Balzarini, Anders Vahlne
Antimicrobial Agents and Chemotherapy - 2008-01-01 -
Tracing of norovirus outbreak strains in mussels collected near sewage
effluents.
Nancy P Nenonen, Charles Hannoun, Peter Horal, Bodil Hernroth, Tomas Bergström
Applied and environmental microbiology - 2008-01-01 -
Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological
follow-up
D. Schledermann, B. T. Andersen, K. Bisgaard, M. Dohse, D. Ejersbo, B. Hoelund, Peter Horal, Magnus Lindh, Walter Ryd
Diagnostic Cytopathology - 2008-01-01 -
Real-time Taqman PCR targeting 14 human papilloma virus
types.
Magnus Lindh, Staffan Görander, Elin Andersson, Peter Horal, Inger Mattsby-Baltzer, Walter Ryd
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 2007-01-01 -
Outbreak of norovirus in Västra Götaland associated with recreational activities at two lakes during August
2004
Benn Sartorius, Yvonne Andersson, Inga Velicko, Birgitta De Jong, Margareta Löfdahl, Kjell-Olof Hedlund, Görel Allestam, Claes Wängsell, Olof Bergstedt, Peter Horal, Peter Ulleryd, Ann Söderstrom
Scandinavian Journal of Infectious Diseases - 2007-01-01 -
Glycine-amide is an active metabolite of the antiretroviral tripeptide
glycyl-prolyl-glycine-amide.
Elin Andersson, Peter Horal, Alenka Jejcic, Stefan Höglund, Jan Balzarini, Anders Vahlne, Bo Svennerholm
Antimicrobial agents and chemotherapy - 2005-01-01 -
Predictive factors and virological response to interferon treatment in children with chronic hepatitis
B.
Ann Söderström, Magnus Lindh, Kajsa Ekholm, Nils Conradi, Peter Horal, Marie Krantz, Catharina Hultgren, Gunnar Norkrans
Scandinavian journal of infectious diseases - 2005-01-01 -
No cross-resistance or selection of HIV-1 resistant mutants in vitro to the antiretroviral tripeptide
glycyl-prolyl-glycine-amide.
Elin Andersson, Peter Horal, Anders Vahlne, Bo Svennerholm
Antiviral research - 2004-01-01 -
Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide
(GPG-NH(2)).
Jan Balzarini, Elin Andersson, Dominique Schols, Paul Proost, Jo Van Damme, Bo Svennerholm, Peter Horal, Anders Vahlne
The international journal of biochemistry & cell biology - 2004-01-01 -
Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis
B.
Charles Hannoun, Peter Horal, Kim Krogsgaard, Magnus Lindh, INTERPRED Trial Group
Journal of medical virology - 2002-01-01 -
Genotype mixtures of hepatitis B virus in patients treated with
interferon.
Charles Hannoun, Kim Krogsgaard, Peter Horal, Magnus Lindh, Trial Group INTERPRED
The Journal of infectious diseases - 2002-01-01 -
The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type
1.
J Su, Elin Andersson, Peter Horal, M H Naghavi, A Palm, Y P Wu, Kristina Eriksson, M Jansson, H Wigzell, Bo Svennerholm, A Vahlne
Journal of human virology - 2001-01-01 -
Phylogenetic origin of hepatitis B virus strains with precore C-1858
variant.
Erik Alestig, Charles Hannoun, Peter Horal, Magnus Lindh
Journal of clinical microbiology - 2001-01-01 -
Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive
assay.
Magnus Lindh, Charles Hannoun, Peter Horal, Kim Krogsgaard, INTERPRED Trial Group
Journal of viral hepatitis - 2001-01-01 -
Hepatitis B virus genotypes in Mongols and Australian
Aborigines.
Erik Alestig, Charles Hannoun, Peter Horal, Magnus Lindh
Archives of virology - 2001-01-01 -
Long-term mutation rates in the hepatitis B virus
genome.
Charles Hannoun, Peter Horal, Magnus Lindh
The Journal of general virology - 2000-01-01 -
Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus
carriers.
Magnus Lindh, Charles Hannoun, Amar P Dhillon, Gunnar Norkrans, Peter Horal
The Journal of infectious diseases - 1999-01-01